Atlas Trials

Efficacy and Safety of Preoperative Sintilimab Plus Nab-paclitaxel and Cisplatin in BR-ESCC Patients

Clinical trial NCT04548440 · COMPLETED

Trial details

NCT number
NCT04548440
Sponsor
Sun Yat-Sen University Cancer Center
Status
COMPLETED
Phase
Phase 2
Study type
INTERVENTIONAL
Esophageal Squamous Cell Carcinoma
Start date
2020-08-31
Primary completion
2022-12-31
Enrollment
50

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.